Biomarker for Creatine Deficiency Syndromes

2016-10-18 02:08:21 | BioPortfolio


Development of a new MS-based biomarker for the early and sensitive diagnosis of creatine deficiency syndromes from plasma


The creatine deficiency syndromes (CDS) are a group of inborn errors of metabolism which interrupt the biosynthesis or transportation of creatine. Individuals with creatine deficiency syndromes classically present with intellectual disabilities and seizure disorders and may present with pyramidal/extrapyramidal neurologic findings and behavioral problems as well.

There are three Cerebral Creatine Deficiency Syndromes:

- Creatine Transporter Deficiency (CTD) - gene SLC6A8

- Guanidinoacetate Methyltransferase Deficiency (GAMT) - gene GAMT

- Arginine: Glycine Amidinotransferase Deficiency (AGAT) - gene GATM

X-linked Creatine Transporter Deficiency (CTD, SLC6A8 Deficiency, CRTR):

X-linked creatine transporter deficiency (CRTR-D) is a creatine deficiency syndrome (see this term) characterized clinically by global developmental delay / intellectual disability (DD/ID) with prominent speech/language delay, autistic behavior and seizures.

CRTR-D has been reported in more than 150 individuals worldwide. The onset of symptoms occurs during infancy, usually before the age of 2 years. Males are mainly affected, but females can also have various combinations and severities of disease manifestations. CRTR-D is consistently characterized by mild to severe intellectual deficit, and expressive speech and language delay. Behavioral disorders (mainly autism and hyperactivity) are present in all affected individuals. Affected individuals often experience seizures and may present low weight gain, muscular hypotonia, and poor muscle mass. Subtle dysmorphic features such as midface hypoplasia, long face, and prominent chin have been reported in various affected male patients. Epilepsy and extrapyramidal symptoms may also occur occasionally. In adult patients, cardiac and gastrointestinal disorders have been reported. Carrier females are typically asymptomatic, but learning disabilities have been described in some. CRTR-D is not a life threatening disease, however live expectancy is limited, particularly in those who have severe seizures and associated physical disabilities.

Guanidinoacetate Methyltransferase Deficiency (GAMT)

Mutations in the GAMT gene are a relatively rare cause of creatine deficiency syndrome. Affected individuals may demonstrate cerebral creatine deficiency on MR spectroscopy and high GAA in urine. Guanidinoacetate methyltransferase deficiency is inherited in an autosomal recessive manner and is caused by biallelic mutations in the GAMT gene. This gene maps to 19p13.3 and is involved in the biosynthesis of creatine. Individuals with GAMT deficiency typically present with severe intellectual disabilities and seizure disorders which may be resistant to drug therapy. Behavioral problems, including autistic behaviors and self-mutilation are common, and pyramidal/extrapyramidal symptoms affect about one-half of patients with GAMT deficiency. Dietary management of GAMT deficiency via manipulation of critical amino acids may improve clinical outcome.

Arginine: Glycine Amidinotransferase (AGAT):

L-Arginine:glycine amidinotransferase (AGAT) deficiency is a very rare type of creatine deficiency syndrome characterized by global developmental delay, intellectual disability, and myopathy. AGAT deficiency is characterized by global developmental delay, appearing in infancy, which can be associated with language impairment and autistic behavior in some, as well as a mild to moderate intellectual disability. Progressive muscle weakness and fatigability have been reported in older patients. Seizures and failure to thrive have also been described. If creatine supplementation is administered early enough, psychomotor delay may be avoided. AGAT deficiency is caused by mutations in the L-arginine:glycine amidinotransferase gene (GATM) located to chromosome 15q15.1. This gene encodes AGAT, which converts arginine and glycine to ornithine and guanidino-acetate in the creatine cycle pathway. AGAT deficiency is transmitted in an autosomal recessive manner and genetic counseling is possible.

New methods, like mass-spectrometry give a good chance to characterize specific metabolic alterations in the blood (plasma) of affected patients that allow diagnosing in the future the disease earlier, with a higher sensitivity and specificity.

Therefore it is the goal of the study to identify and validate a new biochemical marker from the plasma of the affected patients helping to benefit other patients by an early diagnose and thereby with an earlier treatment.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intellectual Disability


Albrecht-Kossel-Institute for Neuroregeneration (AKos) Centre for Mental Health Disease University of Rostock


Not yet recruiting


University of Rostock

Results (where available)

View Results


Published on BioPortfolio: 2016-10-18T02:08:21-0400

Clinical Trials [117 Associated Clinical Trials listed on BioPortfolio]

Targeted Next Generation Sequencing and Intellectual Disability

The purpose is to determine the benefit of next generation sequencing (NGS) targeted on genes involved in intellectual disability for etiologic diagnosis of intellectual disabilities. In o...

Vibration and Cold for Pain Relief During Peripheral Intravenous Cannulation in Children With Intellectual Disability

Needle procedures are the most common and important source of pain and distress in children in the health care setting. Children with intellectual disability from any cause experience pain...

Awareness on Cancer in Persons With Intellectual Disabilities

Context People with intellectual disability (PWIDs), nearly 1,300,000 adults and children in France, develop as many cancers as persons in the general population. However, their tumors are...

Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability

People with intellectual and developmental disabilities (IDD) usually present limitations at adaptive behavior and motor skills, which lead to limitations/barriers in the daily independent...

Mental Health Care Provision for Adults With Intellectual Disability and a Mental Disorder

Quality of mental health services provision for adults with intellectual disability and comorbid mental disorder is considered inadequate and therefore in need of further improvement. Howe...

PubMed Articles [1298 Associated PubMed Articles listed on BioPortfolio]

De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?

Mutations in the X-linked gene MED12 cause at least three different, but closely related, entities of syndromic intellectual disability. Recently, a new syndrome caused by MED13L deleterious variants ...

Successful ageing for people with an intellectual disability.

Successful ageing has not yet been defined in people with an intellectual disability. The purpose of this review is to discuss and define successful ageing in the context of intellectual disability an...

The impact of caring for an adult with intellectual disability and psychiatric comorbidity on carer stress and psychological distress.

Given that carers of individuals with intellectual disability (ID) and carers of individuals with psychiatric disorders experience elevated levels of stress and psychological distress, carers of indiv...

Causal beliefs about intellectual disability and schizophrenia and their relationship with awareness of the condition and social distance.

Evidence on mental illness stigma abounds yet little is known about public perceptions of intellectual disability. This study examined causal beliefs about intellectual disability and schizophrenia an...

The co-occurrence of mental disorders in children and adolescents with intellectual disability/intellectual developmental disorder.

The study summarizes supportive epidemiological data regarding the true co-occurrence (comorbidity) and course of mental disorders in children with intellectual disability/intellectual developmental d...

Medical and Biotech [MESH] Definitions

Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits.

The physician's inability to practice medicine with reasonable skill and safety to the patient due to the physician's disability. Common causes include alcohol and drug abuse, mental illness, physical disability, and senility.

An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Insurance designed to compensate persons who lose wages because of illness or injury; insurance providing periodic payments that partially replace lost wages, salary, or other income when the insured is unable to work because of illness, injury, or disease. Individual and group disability insurance are two types of such coverage. (From Facts on File Dictionary of Health Care Management, 1988, p207)

The compulsory portion of Medicare that is known as the Hospital Insurance Program. All persons 65 years and older who are entitled to benefits under the Old Age, Survivors, Disability and Health Insurance Program or railroad retirement, persons under the age of 65 who have been eligible for disability for more than two years, and insured workers (and their dependents) requiring renal dialysis or kidney transplantation are automatically enrolled in Medicare Part A.

More From BioPortfolio on "Biomarker for Creatine Deficiency Syndromes"

Quick Search

Relevant Topics

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Searches Linking to this Trial